174 related articles for article (PubMed ID: 37809147)
1. Evaluation of Clinical Characteristics and Growth Hormone Response in a Rare Skeletal Dysplasia: Pycnodysostosis.
Ünsal Y; Atar S
Cureus; 2023 Sep; 15(9):e44823. PubMed ID: 37809147
[TBL] [Abstract][Full Text] [Related]
2. A Case Report of Pycnodysostosis Associated with Multiple Pituitary Hormone Deficiencies and Response to Treatment.
Verma V; Singh RK
J Clin Res Pediatr Endocrinol; 2020 Nov; 12(4):444-449. PubMed ID: 32248673
[TBL] [Abstract][Full Text] [Related]
3. Pycnodysostosis: clinical, radiologic, and endocrine evaluation and linear growth after growth hormone therapy.
Soliman AT; Ramadan MA; Sherif A; Aziz Bedair ES; Rizk MM
Metabolism; 2001 Aug; 50(8):905-11. PubMed ID: 11474477
[TBL] [Abstract][Full Text] [Related]
4. Effects and safety of growth hormone treatment in six children with pycnodysostosis.
Renes JS; Sas TCJ; Clement-de Boers A; Zwaveling-Soonawala N; Hannema SE; van der Velden JAEM; van der Kaay DCM; Hokken-Koelega ACS
Horm Res Paediatr; 2024 Jun; ():. PubMed ID: 38838660
[TBL] [Abstract][Full Text] [Related]
5. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF GROWTH HORMONE DEFICIENCY IN ADULTS AND PATIENTS TRANSITIONING FROM PEDIATRIC TO ADULT CARE.
Yuen KCJ; Biller BMK; Radovick S; Carmichael JD; Jasim S; Pantalone KM; Hoffman AR
Endocr Pract; 2019 Nov; 25(11):1191-1232. PubMed ID: 31760824
[No Abstract] [Full Text] [Related]
6. 3M syndrome: Evaluating the clinical and laboratory features and the response of the growth hormone treatment: Single center experience.
Karacan Küçükali G; Keskin M; Aycan Z; Savaş-Erdeve Ş; Çetinkaya S
Eur J Med Genet; 2023 Oct; 66(10):104828. PubMed ID: 37673300
[TBL] [Abstract][Full Text] [Related]
7. Pycnodysostosis: A Growth Hormone Responsive Skeletal Dysplasia.
Omer Sulaiman H; Thalange NKS
AACE Clin Case Rep; 2021; 7(4):231-235. PubMed ID: 34307842
[TBL] [Abstract][Full Text] [Related]
8. The growth hormone cascade: progress and long-term results of growth hormone treatment in growth hormone deficiency.
Grumbach MM; Bin-Abbas BS; Kaplan SL
Horm Res; 1998; 49 Suppl 2():41-57. PubMed ID: 9730672
[TBL] [Abstract][Full Text] [Related]
9. Clinical and genetic evaluation of Danish patients with pycnodysostosis.
Doherty MA; Langdahl BL; Vogel I; Haagerup A
Eur J Med Genet; 2021 Feb; 64(2):104135. PubMed ID: 33429075
[TBL] [Abstract][Full Text] [Related]
10. [Efficacy and safety of recombinant human growth hormone solution in children with growth hormone deficiency in China: a multicenter trial].
Hou L; Luo XP; Du ML; Ma HM; Gong CX; Li YC; Shen SX; Zhao ZH; Liang L; Dong GP; Yan CY; Du HW
Zhonghua Er Ke Za Zhi; 2009 Jan; 47(1):48-52. PubMed ID: 19573383
[TBL] [Abstract][Full Text] [Related]
11. Growth response to growth hormone (GH) treatment in children with GH deficiency (GHD) and those with idiopathic short stature (ISS) based on their pretreatment insulin-like growth factor 1 (IGFI) levels and at diagnosis and IGFI increment on treatment.
Soliman A; Rogol AD; Elsiddig S; Khalil A; Alaaraj N; Alyafie F; Ahmed H; Elawwa A
J Pediatr Endocrinol Metab; 2021 Oct; 34(10):1263-1271. PubMed ID: 34291621
[TBL] [Abstract][Full Text] [Related]
12. Effect of Growth Hormone treatment on Height Velocity of Children with Pycnodysotosis.
Karamizadeh Z; Ilkhanipoor H; Bagheri F
Iran J Pediatr; 2014 Apr; 24(2):161-5. PubMed ID: 25535534
[TBL] [Abstract][Full Text] [Related]
13. Responses to growth hormone (GH) therapy in short children with normal GH secretion and no bone age delay: an analysis of potential factors affecting their response to rhGH therapy. A controlled study.
Soliman AT; Elawwa A; Itani M; Jour C; De Sanctis V
Acta Biomed; 2019 Sep; 90(8-S):43-51. PubMed ID: 31544806
[TBL] [Abstract][Full Text] [Related]
14. The association between growth response to growth hormone and baseline body composition of children with growth hormone deficiency.
Esen I; Demirel F; Tepe D; Kara O; Koc N
Growth Horm IGF Res; 2013 Oct; 23(5):196-9. PubMed ID: 23890535
[TBL] [Abstract][Full Text] [Related]
15. Final height after combined growth hormone and gonadotrophin-releasing hormone analogue therapy in short healthy children entering into normally timed puberty.
Lanes R; Gunczler P
Clin Endocrinol (Oxf); 1998 Aug; 49(2):197-202. PubMed ID: 9828907
[TBL] [Abstract][Full Text] [Related]
16. Pycnodysostosis at otorhinolaryngology.
Baglam T; Binnetoglu A; Fatih Topuz M; Baş Ikizoglu N; Ersu R; Turan S; Sarı M
Int J Pediatr Otorhinolaryngol; 2017 Apr; 95():91-96. PubMed ID: 28576543
[TBL] [Abstract][Full Text] [Related]
17. Growth Hormone Therapy in Children with Kabuki Syndrome: 1-year Treatment Results.
Schott DA; Gerver WJM; Stumpel CTRM
Horm Res Paediatr; 2017; 88(3-4):258-264. PubMed ID: 28793284
[TBL] [Abstract][Full Text] [Related]
18. Long-term Response to Recombinant Human Growth Hormone Therapy in Indian Children with Growth Hormone Deficiency.
Gahlot M; Goyal A; Singh AKC; Jyotsna VP; Gupta N; Khadgawat R
Indian J Endocrinol Metab; 2019; 23(4):446-451. PubMed ID: 31741904
[TBL] [Abstract][Full Text] [Related]
19. [Analysis of the influencing factors of recombinant human growth hormone effect in the children with Turner syndrome].
Li J; Wu W; Liang Y; Luo XP
Zhonghua Er Ke Za Zhi; 2018 Nov; 56(11):866-870. PubMed ID: 30392213
[No Abstract] [Full Text] [Related]
20. Five-year response to growth hormone in children with Noonan syndrome and growth hormone deficiency.
Zavras N; Meazza C; Pilotta A; Gertosio C; Pagani S; Tinelli C; Bozzola M
Ital J Pediatr; 2015 Oct; 41():71. PubMed ID: 26444854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
